Filter News


UT Health Science Center San Antonio co-sponsors international breast cancer symposium Dec. 6-10

December 5, 2016

More than 7,000 oncologists, cancer researchers and patient advocates will converge on San Antonio Dec. 6-10 for the 39th San Antonio Breast Cancer Symposium (SABCS) in the Henry B. Gonzalez Convention Center. Among them will be researchers and oncologists from the Cancer Therapy & Research Center of the UT Health Science Center San Antonio, which founded the conference in 1978.



Thousands to gather for breast cancer symposium

December 5, 2016

More than 7,000 oncologists, cancer researchers and patient advocates will converge on San Antonio Dec. 6-10 for the 39th San Antonio Breast Cancer Symposium (SABCS) in the Henry B. Gonzalez Convention Center.


diabetes in men

Diabetic foot treatment is focus of Dec. 8-10 conference

December 2, 2016

Attention, health care providers with interest in surgical management of the diabetic foot: The UT Health Science Center at San Antonio announces the 11th Annual International External Fixation Symposium, set for Dec. 8-10 at the La Cantera Hill Countr …



New style guide: Institutional logo with full, regental name

December 2, 2016

The use of the logo above is recommended in cases where our new DBA is not yet known/familiar; when advertising in professional journals or websites; and/or in any situation where confusion may still be present.


Lucy Leykum, M.D.

Dr. Leykum honored by Society of General Internal Medicine

December 2, 2016

Luci K. Leykum, M.D., M.B.A., MSc, division chief of General and Hospital Medicine, has been selected as the Society of General Internal Medicine (SGIM) Distinguished Professor of Hospitalist Medicine.



MD News: Hepatitis C screening and treatment: A public health priority

December 1, 2016

In 2016, It is estimated that more than 39,000 persons will be diagnosed with liver cancer and 27,000 persons will die of this disease.


Texas Public Radio: Kangaroo Care May Help Drug Dependent Babies

December 1, 2016

Addiction to prescription drugs and heroin is a national epidemic. Read the full story at Texas Public Radio


Clinical Oncology News: SABCS 2016: Everolimus Added to Fulvestrant Upped PFS in Postmenopausal HR+ Breast Ca Pts

December 1, 2016

Adding everolimus to fulvestrant in postmenopausal women with hormone receptor (HR)-positive/HER2-negative, aromatase inhibitor (AI)-resistant metastatic breast cancer improved progression-free survival (PFS) to 10.4 months, compared with 5.1 months fo …


Philly Purge: Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection

December 1, 2016

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from three Phase 2 clinical trials evaluating MK-3682B (MK-3682/grazoprevir/ruzasvir1), the company’s investigational all-oral, triple-c …


Cancer Network: Chemo Plus Veliparib Improves Responses in BRCA-Mutant Breast Cancer

December 1, 2016

Adding the PARP inhibitor veliparib to carboplatin and paclitaxel chemotherapy significantly increased response rates among women with BRCA1 or BRCA2 mutations and locally recurrent or metastatic breast cancer, according to a randomized phase II trial. …


Filter news